EXPOSED!… CDC Caught Removing Page From Website Admitting 1955 To 1963 Polio Vaccine Was Laced With SV40 Cancer Virus!

September 3rd, 2015

Awake Goy

The CDC quickly removed a page from their website admitting from 1955 to 1963, well over 98 MILLION Americans received one
or more doses of polio vaccine. A proportion of this vaccine was contaminated with a cancer causing
polyomavirus called SV40. ~ IWB

It has been estimated that anywhere from 10 to 30 million
Americans could have received an SV40 contaminated dose of the vaccine.

See the cached CDC page HERE

Michele Carbone, Assistant Professor of Pathology at Loyola
University in Chicago, has recently isolated fragments of the SV-40
virus in human bone cancers and in a lethal form of lung cancer called
mesothelioma.

He found SV-40 in 33% of the osteosarcoma bone cancers
studied, in 40% of other bone cancers, and in 60% of the mesotheliomas
lung cancers, writes Geraldo Fuentes.

Dr. Michele Carbone openly acknowledged HIV/AIDS was spread by the
hepatitis B vaccine produced by Merck & Co. during the early 1970s.

It was the first time since the initial transmissions took place in
1972-74, that a leading expert in the field of vaccine manufacturing and
testing has openly admitted the Merck & Co. liability for AIDS.

SV40 is an abbreviation for Simian vacuolating virus 40 or Simian
virus 40, a polyomavirus that is found in both monkeys and humans. Like
other polyomaviruses, SV40 is a DNA virus that has been found to cause
tumors and cancer.

SV40 is believed to suppress the transcriptional properties of the
tumor-suppressing genes in humans through the SV40 Large T-antigen and
SV40 Small T-antigen. Mutated genes may contribute to uncontrolled
cellular proliferation, leading to cancer.

The matter-of-fact disclosure came during discussions of polio
vaccines contaminated with SV40 virus which caused cancer in nearly
every species infected by injection.

Many authorities now admit much,
possibly most, of the world’s cancers came from the Salk and Sabin polio
vaccines, and hepatitis B vaccines, produced in monkeys and chimps.

It is said mesothelioma is a result of asbestos exposure, but research
reveals that 50% of the current mesotheliomas being treated no longer
occurs due to asbestos but rather the SV-40 virus contained in the polio
vaccination.

In addition, according to researchers from the Institute
of Histology and General Embryology of the University of Ferrara, SV-40
has turned up in a variety other tumors.

By the end of 1996, dozens of
scientists reported finding SV40 in a variety of bone cancers and a wide
range of brain cancers, which had risen 30 percent over the previous 20
years.

A Greater Perspective on Aerial Spraying and SV40

The Defense Sciences Office of the Pathogen Countermeasures Program,
in September 23, 1998 funded the University of Michigan’s principal
investigator, Dr. James Baker, Jr. Dr. Baker, Director of Michigan
Nanotechnology Institute for Medicine and Biological Sciences under
several DARPA grants.

Dr. Baker developed and focused on preventing
pathogens from entering the human body, which is a major goal in the
development of counter measures to Biological Warfare.

This research
project sought to develop a composite material that will serve as a
pathogen avoidance barrier and post-exposure therapeutic agent to be
applied in a topical manner to the skin and mucous membranes.

The
composite is modeled after the immune system in that it involves
redundant, non-specific and specific forms of pathogen defense and
inactivation.

This composite material is now utilized in many nasal
vaccines and vector control through the use of hydro-gel, nanosilicon
gels and actuator materials in vaccines.

Through Dr. Baker’s research at the University of Michigan; he
developed dendritic polymers and their application to medical and
biological science. He co-developed a new vector system for gene
transfer using synthetic polymers.

These studies have produced striking
results and have the potential to change the basis of gene transfer
therapy. Dendrimers are nanometer-sized water soluble polymers that can
conjugate to peptides or arbohydrates to act as decoy molecules to
inhibit the binding of toxins and viruses to cells.

They can act also as
complex and stabilize genetic material for prolonged periods of time,
as in a “time released or delayed gene transfer”.

Through Dr. Baker’s
ground breaking research many pharmaceutical and biological pesticide
manufacturers can use these principles in DNA vaccines specific
applications that incorporate the Simian Monkey Virus SV40.

WEST NILE VIRUS SPRAYING

In 2006 Michael Greenwood wrote an article for the Yale School of
Public Health entitled, “Aerial Spraying Effectively Reduces Incidence
of West Nile Virus (WNV) in Humans.”

The article stated that the
incidence of human West Nile virus cases can be significantly reduced
through large scale aerial spraying that targets adult mosquitoes,
according to research by the Yale School of Public Health and the
California Department of Public Health.

Under the mandate for aerial spraying for specific vectors that pose a
threat to human health, aerial vaccines known as DNA Vaccine
Enhancements and Recombinant Vaccine against WNV may be tested or used
to “protect” the people from vector infection exposures.

DNA vaccine
enhancements specifically use Epstein-Barr viral capside’s with multi
human complement class II activators to neutralize antibodies. The
recombinant vaccines against WNV use Rabbit Beta-globulin or the poly
(A) signal of the SV40 virus.

In early studies of DNA vaccines it was
found that the negative result studies would go into the category of
future developmental research projects in gene therapy.

During the
studies of poly (A) signaling of the SV40 for WNV vaccines, it was
observed that WNV will lie dormant in individuals who were exposed to
chicken pox, thus upon exposure to WNV aerial vaccines the potential for
the release of chicken pox virus would cause a greater risk to having
adult onset Shingles.

CALIFORNIA AERIAL SPRAYING for WNV and SV40

In February 2009 to present date, aerial spraying for the WNV occurred
in major cities within the State of California. During spraying of
Anaheim, CA a Caucasian female (age 50) was exposed to heavy spraying,
while doing her daily exercise of walking several miles.

Heavy
helicopter activity occurred for several days in this area. After
spraying, she experienced light headedness, nausea, muscle aches and
increased low back pain.

She was evaluated for toxicological mechanisms
that were associated with pesticide exposure due to aerial spraying
utilizing advanced biological monitoring testing.

The test results which
included protein band testing utilizing Protein Coupled Response (PCR)
methods were positive for KD-45. KD-45 is the protein band for SV-40
Simian Green Monkey virus.

Additional tests were performed for
Epstein-Barr virus capside and Cytomeglia virus which are used in
bioengineering for gene delivery systems through viral protein envelope
and adenoviral protein envelope technology.

The individual was positive
for both; indicating a highly probable exposure to a DNA vaccination
delivery system through nasal inhalation.

The question of the century is how many other viruses and toxins are
within current day vaccines that we’ll only find out about in a few
decades?

Aluminum gels or aluminum salts are vaccine ingredients that have
been used in vaccines since the 1930s. Small amounts of aluminum are
added to help the body build stronger immunity against the germ in the
vaccine. Aluminum is one of the most common metals found in nature and
is present in air, food, and water. The amount of aluminum present in
vaccines is low and is regulated by the U.S. Food and Drug
Administration (FDA).

Source

Abstract

Aluminum is an experimentally demonstrated neurotoxin and the most
commonly used vaccine adjuvant. Despite almost 90 years of widespread
use of aluminum adjuvants, medical science’s understanding about their
mechanisms of action is still remarkably poor.

There is also a
concerning scarcity of data on toxicology and pharmacokinetics of these
compounds. In spite of this, the notion that aluminum in vaccines is
safe appears to be widely accepted.

Experimental research, however,
clearly shows that aluminum adjuvants have a potential to induce serious
immunological disorders in humans.

In particular, aluminum in adjuvant
form carries a risk for autoimmunity, long-term brain inflammation and
associated neurological complications and may thus have profound and
widespread adverse health consequences.

In our opinion, the possibility
that vaccine benefits may have been overrated and the risk of potential
adverse effects underestimated, has not been rigorously evaluated in the
medical and scientific community.

We hope that the present paper will
provide a framework for a much needed and long overdue assessment of
this highly contentious medical issue.

Source